The pharmaceutical landscape for diabetes is shifting, and transdermal GLP-1 delivery systems represent a promising development. Unlike subcutaneous injections, this method offers a simpler way to administer GLP-1 https://idahpyx857303.59bloggers.com/41306328/glp-1-patches-a-new-approach-to-blood-sugar-control